Gleaning relapse risk from B cell phenotype: decreased CD5(+) B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis

Lignende værker

• Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab
  af: Bunch, Donna O’Dell, et al.
  Udgivet: (2013)
• Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis
  af: Poulton, Caroline J., et al.
  Udgivet: (2013)
• What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population
  af: Berg, Elisabeth A.B., et al.
  Udgivet: (2014)
• Predictors of Treatment Outcomes in ANCA-Associated Vasculitis with Severe Kidney Failure
  af: Lee, Taewoo, et al.
  Udgivet: (2014)
• Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
  af: McGregor, JulieAnne G., et al.
  Udgivet: (2015)